Greaves MF, Janossy G., Peto J., Kay H.Immunologically defined subclasses of acute lymphoblastic leukaemia: their relationship to presentation features and prognosis. Br J Haematol1981;48:179-97.
2.
Crist WM, Grossi CE, Pullen J., Cooper MDImmunological markers in childhood acute lymphocytic leukemia. Semin Oncol1985;12:105-21.
3.
Foon KA, Todd RF III. Immunologic classification of leukemia and lymphoma. Blood1986;68:1-31.
4.
Greaves MFDifferentiation-linked leukemogenesis in lymphocytes. Science1986;234:697-704.
5.
Pierce JH, Eva A., Aaronson SAInteractions of oncogenes with haematopoietic cells. Clin Haematol1986;15:573-96.
6.
Yunis JJ, Brunning RDPrognostic significance of chromosomal abnormalities in acute leukemias and myelodysplastic syndromes. Clin Haematol1986 ;15:597-620.
7.
Croce CM, Thierfelder W., Erikson J., et al. Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a c locus in Burkitt lymphoma cells. Proc Natl Acad Sci USA1983;80:6922-6.
8.
Dalla Favera R, Begni M., Erikson J., et al. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells . Proc Natl Acad Sci USA1982; 79:7824-7.
9.
Showe LC, Croce CMChromosome translocation in B- and T-cell neoplasias. Semin Hematol1986;23:237-44.
10.
Cronkite EPChemical leukemogenesis: benzene as a model . Semin Hematol1987;24:2-11.
11.
Pendergrass TWEpidemiology of acute lymphoblastic leukemia . Semin Oncol1985;12:80-91.
12.
McGrath IT, O'Conor GT, Ramot B.Pathogenesis of Leukemias and Lymphomas: Environmental Influences . New York: Raven Press, 1984; 1-128.
13.
Miller DR, Leikin S., Albo V., et al. Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL). Br J Haematol1981 ;48:199-206.
14.
Lilleyman JS , Hann IM, Stevens RF, et al. The FrenchAmerican British morphological classification of childhood lymphoblastic leukaemia and its clinical significance. J Clin Pathol1986 ;39:998-1002.
15.
Suarez C., Miller DR, Steinherz PG, et al. DNA and RNA determinations in 111 cases of childhood acute lymphoblastic leukemia (ALL) by flow cytometry: correlation of FAB classification with DNA stemline and proliferation. Br J Haematol1985;60:677-86.
16.
Miller DR, Coccia PF, Bleyer WA, et al. Early response to induction therapy predicts early and late relapse in childhood acute lymphoblastic leukemia. Blood1986;68 (Suppl 1):227a.
17.
Mirro J., Zipf TF, Pui C-H., et al. Acute mixed lineage leukemia: Clinicopathologic correlation and prognostic significance. Blood1985;65:1115-23.
18.
Crist W., Boyett J., Roper M., et al. Pre B-cell leukemia responds poorly to treatment: a Pediatric Oncology Group study. Blood1985;63:407-14.
19.
Korsmeyer SJ , Arnold A., Bakhshi A., et al. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphoblastic leukemia. J Clin Oncol1983;71:301-13.
20.
Greaves MF, Mizutani S., Furley Ajw, et al. Differentiation-linked gene rearrangement in acute lymphoblastic leukemia. Clin Haematol1986;15:621-39.
21.
Hammond D. Sather H, Nesbit M., et al. Analysis of prognostic factors in acute lymphoblastic leukemia. Med Pediatr Oncol1986;14:124-34.
22.
Williams DL , Haber J., Murphy SB, et al. Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia . Blood1986;68:205-12.
23.
Look ATThe emerging genetics of acute lymphoblastic leukemia: clinical and biologic implications. Semin Oncol1985;12:92-104.
24.
Crist W., Pullen J., Boyett J., et al. Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: A Pediatric Oncology Group Study. Blood1986;67:135-40.
25.
Heisterkamp N. , Stam K., Groffen J., et al.Structural organization of the bcr gene and its role in the Ph1 translocation. Nature1985;306:239-42.
26.
Niemeyer CM, Hitchcock-Bryan S., Sallan SEComparative analysis of treatment programs for childhood acute lymphoblastic leukemia. Semin Oncol1985;12:122-30.
27.
Rivera GK, Mauer AMControversies in the management of childhood acute lymphoblastic leukemia: treatment intensification, CNS leukemia, and prognostic factors. Semin Hematol1987;24:12-26.
28.
Bleyer WA, Poplack DGProphylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol1985;12:131-48.
29.
Albo V., Miller DR, Leikin S., et al. Nine brain tumors as a late effect in children "cured" of acute lymphoblastic leukemia (ALL) from a single protocol. Proc Amer Soc Clin Oncol1985;4:172.
30.
Chessells JMAcute leukemia in children. Clin Haematol1986;15:727-53.
31.
Nesbit ME, Sather HN, Robison LL, et al. Randomized study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukemia. J Clin Oncol1983;1:308-16.
32.
Miller, DR, Leikin S., Albo V., et al. Fate after occult testicular relapse (OTR) in childhood acute lymphoblastic leukemia (ALL): the role of testicular biopsy. Proc Amer Assoc Cancer Research1983;24:161, Abstract 636.
33.
Rivera GK, Buchanan G., Boyett JM, et al. Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group study. New Engl J Med1986;315:273-6.
34.
Nesbit ME, Woods WG, Weisdorf D., et al. Bone marrow transplantation for acute lymphoblastic leukemia . Semin Oncol1985;12:149-59.
35.
Champlin RE , Gale RPBone marrow transplantation in acute leukemia: recent advances and comparison with alternative therapies. Semin Hematol1987;24:55-67.